PsyBio Therapeutics EPS
What is the EPS of PsyBio Therapeutics?
The EPS of PsyBio Therapeutics Corp. is -0.12
What is the definition of EPS?
Earnings per share (EPS) is the portion of a company’s profit allocated to each outstanding share of common stock. It is adjusted for dilution and calculated over trailing twelve months.
ttm (trailing twelve months)
Earnings per share is the monetary value of earnings per outstanding share of common stock for a company. Preferred stock rights have precedence over common stock. Therefore, dividends on preferred shares are subtracted before calculating the EPS. When preferred shares are cumulative, annual dividends are deducted whether or not they have been declared. Dividends in arrears are not relevant when calculating EPS. The EPS is usually calculated as profit without preferred dividends divided by weighted average of common stock shares over the past twelve months.
EPS of companies in the Health Care sector on TSXV compared to PsyBio Therapeutics
What does PsyBio Therapeutics do?
PsyBio Therapeutics Corp., a biotechnology company, focuses on the research, development, and commercialization of psychedelic-inspired regulated medicines for the treatment of mental health and other disorders in the United States. The company is headquartered in Coconut Creek, Florida.
Companies with eps similar to PsyBio Therapeutics
- Trident Acquisitions has EPS of -0.12
- Vatic Ventures has EPS of -0.12
- Tonies Se Eo 1 has EPS of -0.12
- BASE has EPS of -0.12
- Hidili Industry International Development has EPS of -0.12
- Punjab National Bank has EPS of -0.12
- PsyBio Therapeutics has EPS of -0.12
- Cyclopharm has EPS of -0.11
- Medcolcanna Organics has EPS of -0.11
- Intrasense SA has EPS of -0.11
- Asia Cassava Resources has EPS of -0.11
- Heliostar Metals has EPS of -0.11
- Largo Resources has EPS of -0.11